- Home
- DGLY vs GTBP Comparison
DGLY vs GTBP Comparison
Compare DGLY & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- GTBP
- Stock Information
- Founded
- DGLY 2004
- GTBP 1965
- Country
- DGLY United States
- GTBP United States
- Employees
- DGLY N/A
- GTBP N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- DGLY Technology
- GTBP Health Care
- Exchange
- DGLY Nasdaq
- GTBP Nasdaq
- Market Cap
- DGLY 3.2M
- GTBP 2.6M
- IPO Year
- DGLY N/A
- GTBP N/A
- Fundamental
- Price
- DGLY $1.82
- GTBP $0.67
- Analyst Decision
- DGLY
- GTBP Strong Buy
- Analyst Count
- DGLY 0
- GTBP 1
- Target Price
- DGLY N/A
- GTBP $11.00
- AVG Volume (30 Days)
- DGLY 26.0K
- GTBP 4.5M
- Earning Date
- DGLY 08-18-2025
- GTBP 11-13-2025
- Dividend Yield
- DGLY N/A
- GTBP N/A
- EPS Growth
- DGLY N/A
- GTBP N/A
- EPS
- DGLY N/A
- GTBP N/A
- Revenue
- DGLY $18,612,519.00
- GTBP N/A
- Revenue This Year
- DGLY N/A
- GTBP N/A
- Revenue Next Year
- DGLY $7.38
- GTBP N/A
- P/E Ratio
- DGLY N/A
- GTBP N/A
- Revenue Growth
- DGLY N/A
- GTBP N/A
- 52 Week Low
- DGLY $1.66
- GTBP $0.55
- 52 Week High
- DGLY $119.00
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- DGLY 42.79
- GTBP 43.49
- Support Level
- DGLY $1.76
- GTBP $0.65
- Resistance Level
- DGLY $1.87
- GTBP $0.78
- Average True Range (ATR)
- DGLY 0.09
- GTBP 0.07
- MACD
- DGLY -0.02
- GTBP 0.01
- Stochastic Oscillator
- DGLY 15.00
- GTBP 9.16
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.